ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,769Medicare Part D Prescriptions Filled, Including Refills

Rank: 103 out of 939

$827K Total Retail Price of All Prescriptions

Rank: 85 out of 939

558 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 558 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 558 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 11,839 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
SIMVASTATIN 576 472 1 2
LISINOPRIL 527 401 2 3
OMEPRAZOLE 523 388 3 5
GABAPENTIN 497 405 4 11
LEVOTHYROXINE SODIUM 443 362 5 4
FUROSEMIDE 427 340 6 7
HYDROCODONE-ACETAMINOPHEN 396 262 S3 7 1
AMLODIPINE BESYLATE 341 260 8 6
TRAMADOL HCL 323 238 9 16
MELOXICAM 302 250 10 14
POTASSIUM CHLORIDE 293 275 11 9
WARFARIN SODIUM 285 237 12 17
CITALOPRAM HBR 271 174 13 15
METFORMIN HCL 269 186 14 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 245 202 15 23
METOPROLOL TARTRATE 225 151 16 10
DONEPEZIL HCL 151 140 17 30
METOPROLOL SUCCINATE 150 116 18 21
SERTRALINE HCL 149 101 19 24
NEXIUM 147 70 20 18
TRIAMTERENE-HCTZ 146 131 21 33
CYMBALTA 142 112 22 44
TRAZODONE HCL 139 90 23 26
ATENOLOL 138 113 24 19
ESCITALOPRAM OXALATE 135 100 25 61
ZOLPIDEM TARTRATE 134 61 26 20
PRAVASTATIN SODIUM 132 120 27 13
MIRTAZAPINE 123 84 28 56
HYDROCHLOROTHIAZIDE 123 99 28 12
ATORVASTATIN CALCIUM 122 90 30 22
FENOFIBRATE 119 81 31 83
NAMENDA 113 113 32 49
ABILIFY 109 76 33 156
AZITHROMYCIN 109 74 33 32
ALENDRONATE SODIUM 109 97 33 40
TAMSULOSIN HCL 107 98 36 27
LOSARTAN POTASSIUM 107 101 36 29
ISOSORBIDE MONONITRATE ER 103 93 38 53
KLOR-CON M20 101 79 39 90
LYRICA 101 66 39 63
SPIRONOLACTONE 100 87 41 71
CLOPIDOGREL 97 68 42 28
PLAVIX 95 73 43 48
OXCARBAZEPINE 93 68 44 227
DIGOXIN 91 65 45 45
AMITRIPTYLINE HCL 91 81 R 45 38
QUETIAPINE FUMARATE 90 70 47 69
ROPINIROLE HCL 89 64 48 78
GLIPIZIDE 88 67 49 52
NOVOLIN R 87 71 50 217
LOSARTAN-HYDROCHLOROTHIAZIDE 87 76 50 55
CARVEDILOL 85 65 52 25
VERAPAMIL ER 84 65 53 85
GLYBURIDE-METFORMIN HCL 82 65 R 54 98
OXYBUTYNIN CHLORIDE ER 82 61 54 167
DIOVAN 81 56 56 50
NIFEDIPINE ER 79 69 57 105
PHENYTOIN SODIUM EXTENDED 78 53 58 99
SPIRIVA 77 65 59 73
FAMOTIDINE 73 50 60 62
CYCLOBENZAPRINE HCL 71 32 R 61 36
DIVALPROEX SODIUM 71 38 61 95
ZETIA 69 35 63 103
METOCLOPRAMIDE HCL 68 52 64 119
VENTOLIN HFA 67 37 65 80
CLONIDINE HCL 65 30 66 39
LANTUS 63 18 67 59
CRESTOR 63 63 67 34
PANTOPRAZOLE SODIUM 63 61 67 66
FLUTICASONE PROPIONATE 57 34 70 43
RISPERIDONE 56 35 71 82
SEROQUEL 56 49 71 139
ADVAIR DISKUS 54 43 73 60
PROMETHAZINE HCL 54 26 R 73 68
NITROFURANTOIN MONO-MACRO 53 42 75 180
FLUOXETINE HCL 53 44 75 47
PROAIR HFA 52 18 77 41
DOXYCYCLINE HYCLATE 52 36 77 84
GLIPIZIDE ER 52 49 77 88
ACTOS 51 35 80 141
CARISOPRODOL 51 0 R 80 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 13, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.